icd-idb.org - Islamic corporation for the Development of the private sector

Jamjoom Pharma is a recently established pharmaceutical production company belonging to the Saudi group Abdulatif Jamjoom & Bros. The Company is specialized in the production of vitamins as well as nutritional, ophtalmic, and dermatological products.

Jamjoom Pharma has a modern plant, with state-of-the art technology, located in the industrial zone of Jeddah. Production has started in the year 2000, and comprises tablets and capsules, skin ointments and creams, ampules and oral liquids.

Part of the output is sold in the Saudi market and the rest is exported to neighboring countries, such as GCC countries, Sudan and Yemen.

ICD has extended financing amounting to USD 2.6 million to Jamjoom Pharma to enhance its operations.

The financing of ICD combines three modes: (i) an installment sale financing of USD 1.44 million for the acquisition of equipment, (ii) an Istisna'a financing of USD 0.795 million for the manufacturing of a stock of medicines, and (iii) a Murabaha financing amounting to USD 0.456 million for the acquisition of raw and packaging material.

The contribution of ICD in this project aims at developing local production capacity in a vital sector of a member country and help promoting exports.


		•Sodegrain Flour Mill Project. •Al Hadha Grain Handing & Silos. •Line of Financing: Byblos Bank SAL. •JamJoom Pharma Expansion Project. • Plastic Packaging Expansion Project (Daboul). • Glass Containers Project (GCC). • SabaFon Expansion Project. • Dairy Plant Project (ICFI). • Injazat Technology Fund. • The International Islamic Rating Agency (IIRA) • Middle East Healthcare Company (MEAHCO) • Thuraya Satellite Telecom Company • Jamjoom Pharma • Advisory Services Feasibility Study for the Investment Fund for the Development of Awqaf • Adritec Private Placement • Sudatel Telephone Exchanges Project • Jordan Pharmaceutical Company • Al-Ahlia Mineral Water Company • Syrian Saudi Chemicals Company



.	.		.	.

	.